Shanghai Fosun Pharmaceutical Group Co Stock | 600196.SS | CNE000000X38 |

Date	Shanghai Fosun Pharmaceutical Group Co Price
11/29/2024	26.68 undefined
11/28/2024	26.31 undefined
11/27/2024	26.39 undefined
11/26/2024	26.01 undefined
11/25/2024	26.33 undefined
11/22/2024	26.24 undefined
11/21/2024	27.29 undefined
11/20/2024	27.27 undefined
11/19/2024	26.85 undefined
11/18/2024	26.67 undefined
11/15/2024	26.81 undefined
11/14/2024	27.06 undefined
11/13/2024	27.69 undefined
11/12/2024	27.78 undefined
11/11/2024	27.48 undefined
11/8/2024	27.46 undefined
11/7/2024	27.55 undefined
11/6/2024	27.10 undefined
11/5/2024	27.19 undefined
11/4/2024	26.84 undefined
11/1/2024	26.51 undefined

Date	Shanghai Fosun Pharmaceutical Group Co Revenue	Shanghai Fosun Pharmaceutical Group Co EBIT	Shanghai Fosun Pharmaceutical Group Co Net Income
2026e	48.72 B undefined	3.87 B undefined	3.23 B undefined
2025e	46.62 B undefined	3.3 B undefined	2.76 B undefined
2024e	42.86 B undefined	3.01 B undefined	2.31 B undefined
2023	41.4 B undefined	1.29 B undefined	2.39 B undefined
2022	43.95 B undefined	3.5 B undefined	3.73 B undefined
2021	39.01 B undefined	2.55 B undefined	4.74 B undefined
2020	30.31 B undefined	2.64 B undefined	3.66 B undefined
2019	28.59 B undefined	2.49 B undefined	3.32 B undefined
2018	24.92 B undefined	2.29 B undefined	2.71 B undefined
2017	18.53 B undefined	2.24 B undefined	3.12 B undefined
2016	14.63 B undefined	1.64 B undefined	2.81 B undefined
2015	12.61 B undefined	1.36 B undefined	2.46 B undefined
2014	12.03 B undefined	1.11 B undefined	2.11 B undefined
2013	10 B undefined	1.03 B undefined	1.58 B undefined
2012	7.34 B undefined	553 M undefined	1.56 B undefined
2011	6.49 B undefined	324 M undefined	1.17 B undefined
2010	4.56 B undefined	163 M undefined	864 M undefined
2009	3.87 B undefined	157 M undefined	2.5 B undefined
2008	3.77 B undefined	118 M undefined	691 M undefined
2007	3.69 B undefined	164 M undefined	626 M undefined
2006	4.08 B undefined	92 M undefined	258 M undefined
2005	2.99 B undefined	143 M undefined	159 M undefined
2004	2.43 B undefined	153 M undefined	215 M undefined

	Revenue	EBIT	Net Income
2004	2.43 B CNY	153 M CNY	215 M CNY
2005	2.99 B CNY	143 M CNY	159 M CNY
2006	4.08 B CNY	92 M CNY	258 M CNY
2007	3.69 B CNY	164 M CNY	626 M CNY
2008	3.77 B CNY	118 M CNY	691 M CNY
2009	3.87 B CNY	157 M CNY	2.5 B CNY
2010	4.56 B CNY	163 M CNY	864 M CNY
2011	6.49 B CNY	324 M CNY	1.17 B CNY
2012	7.34 B CNY	553 M CNY	1.56 B CNY
2013	10 B CNY	1.03 B CNY	1.58 B CNY
2014	12.03 B CNY	1.11 B CNY	2.11 B CNY
2015	12.61 B CNY	1.36 B CNY	2.46 B CNY
2016	14.63 B CNY	1.64 B CNY	2.81 B CNY
2017	18.53 B CNY	2.24 B CNY	3.12 B CNY
2018	24.92 B CNY	2.29 B CNY	2.71 B CNY
2019	28.59 B CNY	2.49 B CNY	3.32 B CNY
2020	30.31 B CNY	2.64 B CNY	3.66 B CNY
2021	39.01 B CNY	2.55 B CNY	4.74 B CNY
2022	43.95 B CNY	3.5 B CNY	3.73 B CNY
2023	41.4 B CNY	1.29 B CNY	2.39 B CNY
2024e	42.86 B CNY	3.01 B CNY	2.31 B CNY
2025e	46.62 B CNY	3.3 B CNY	2.76 B CNY
2026e	48.72 B CNY	3.87 B CNY	3.23 B CNY

Shanghai Fosun Pharmaceutical Group Co Gross margin	Shanghai Fosun Pharmaceutical Group Co Profit margin	Shanghai Fosun Pharmaceutical Group Co EBIT margin	Shanghai Fosun Pharmaceutical Group Co Profit margin
2026e	47.54 %	7.93 %	6.62 %
2025e	47.54 %	7.07 %	5.92 %
2024e	47.54 %	7.03 %	5.4 %
2023	47.54 %	3.11 %	5.76 %
2022	47.09 %	7.97 %	8.49 %
2021	47.97 %	6.54 %	12.14 %
2020	55.47 %	8.72 %	12.09 %
2019	59.57 %	8.71 %	11.62 %
2018	58.34 %	9.17 %	10.87 %
2017	58.84 %	12.06 %	16.86 %
2016	53.81 %	11.23 %	19.18 %
2015	49.78 %	10.81 %	19.51 %
2014	43.87 %	9.19 %	17.57 %
2013	44.22 %	10.3 %	15.84 %
2012	43.62 %	7.53 %	21.31 %
2011	37.63 %	5 %	17.98 %
2010	33.9 %	3.58 %	18.97 %
2009	32.02 %	4.05 %	64.51 %
2008	27.67 %	3.13 %	18.31 %
2007	26.59 %	4.44 %	16.95 %
2006	21.34 %	2.25 %	6.32 %
2005	29.98 %	4.78 %	5.32 %
2004	31.22 %	6.31 %	8.87 %

	Gross margin	EBIT margin	Profit margin
2004	31.22 %	6.31 %	8.87 %
2005	29.98 %	4.78 %	5.32 %
2006	21.34 %	2.25 %	6.32 %
2007	26.59 %	4.44 %	16.95 %
2008	27.67 %	3.13 %	18.31 %
2009	32.02 %	4.05 %	64.51 %
2010	33.9 %	3.58 %	18.97 %
2011	37.63 %	5 %	17.98 %
2012	43.62 %	7.53 %	21.31 %
2013	44.22 %	10.3 %	15.84 %
2014	43.87 %	9.19 %	17.57 %
2015	49.78 %	10.81 %	19.51 %
2016	53.81 %	11.23 %	19.18 %
2017	58.84 %	12.06 %	16.86 %
2018	58.34 %	9.17 %	10.87 %
2019	59.57 %	8.71 %	11.62 %
2020	55.47 %	8.72 %	12.09 %
2021	47.97 %	6.54 %	12.14 %
2022	47.09 %	7.97 %	8.49 %
2023	47.54 %	3.11 %	5.76 %
2024e	47.54 %	7.03 %	5.4 %
2025e	47.54 %	7.07 %	5.92 %
2026e	47.54 %	7.93 %	6.62 %

Date	Shanghai Fosun Pharmaceutical Group Co Sales per Share	Shanghai Fosun Pharmaceutical Group Co EBIT per share	Shanghai Fosun Pharmaceutical Group Co Earnings per Share
2026e	23.09 undefined	0 undefined	1.53 undefined
2025e	22.09 undefined	0 undefined	1.31 undefined
2024e	20.31 undefined	0 undefined	1.1 undefined
2023	15.51 undefined	0.48 undefined	0.89 undefined
2022	16.86 undefined	1.34 undefined	1.43 undefined
2021	15.22 undefined	1 undefined	1.85 undefined
2020	11.82 undefined	1.03 undefined	1.43 undefined
2019	11.15 undefined	0.97 undefined	1.3 undefined
2018	9.88 undefined	0.91 undefined	1.07 undefined
2017	7.53 undefined	0.91 undefined	1.27 undefined
2016	6.28 undefined	0.71 undefined	1.2 undefined
2015	5.43 undefined	0.59 undefined	1.06 undefined
2014	5.24 undefined	0.48 undefined	0.92 undefined
2013	4.46 undefined	0.46 undefined	0.71 undefined
2012	3.28 undefined	0.25 undefined	0.7 undefined
2011	3.41 undefined	0.17 undefined	0.61 undefined
2010	2.42 undefined	0.09 undefined	0.46 undefined
2009	2.09 undefined	0.08 undefined	1.35 undefined
2008	2.03 undefined	0.06 undefined	0.37 undefined
2007	1.99 undefined	0.09 undefined	0.34 undefined
2006	2.2 undefined	0.05 undefined	0.14 undefined
2005	1.84 undefined	0.09 undefined	0.1 undefined
2004	1.5 undefined	0.09 undefined	0.13 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	1.5 CNY	0.09 CNY	0.13 CNY
2005	1.84 CNY	0.09 CNY	0.1 CNY
2006	2.2 CNY	0.05 CNY	0.14 CNY
2007	1.99 CNY	0.09 CNY	0.34 CNY
2008	2.03 CNY	0.06 CNY	0.37 CNY
2009	2.09 CNY	0.08 CNY	1.35 CNY
2010	2.42 CNY	0.09 CNY	0.46 CNY
2011	3.41 CNY	0.17 CNY	0.61 CNY
2012	3.28 CNY	0.25 CNY	0.7 CNY
2013	4.46 CNY	0.46 CNY	0.71 CNY
2014	5.24 CNY	0.48 CNY	0.92 CNY
2015	5.43 CNY	0.59 CNY	1.06 CNY
2016	6.28 CNY	0.71 CNY	1.2 CNY
2017	7.53 CNY	0.91 CNY	1.27 CNY
2018	9.88 CNY	0.91 CNY	1.07 CNY
2019	11.15 CNY	0.97 CNY	1.3 CNY
2020	11.82 CNY	1.03 CNY	1.43 CNY
2021	15.22 CNY	1 CNY	1.85 CNY
2022	16.86 CNY	1.34 CNY	1.43 CNY
2023	15.51 CNY	0.48 CNY	0.89 CNY
2024e	20.31 CNY	0 CNY	1.1 CNY
2025e	22.09 CNY	0 CNY	1.31 CNY
2026e	23.09 CNY	0 CNY	1.53 CNY

	Number of stocks
2004	1.61 B Aktien
2005	1.62 B Aktien
2006	1.86 B Aktien
2007	1.86 B Aktien
2008	1.86 B Aktien
2009	1.86 B Aktien
2010	1.89 B Aktien
2011	1.9 B Aktien
2012	2.24 B Aktien
2013	2.24 B Aktien
2014	2.3 B Aktien
2015	2.32 B Aktien
2016	2.33 B Aktien
2017	2.46 B Aktien
2018	2.52 B Aktien
2019	2.56 B Aktien
2020	2.56 B Aktien
2021	2.56 B Aktien
2022	2.61 B Aktien
2023	2.67 B Aktien
2024e	2.67 B Aktien
2025e	2.67 B Aktien
2026e	2.67 B Aktien

Date	Shanghai Fosun Pharmaceutical Group Co Dividend
2026e	0.44 undefined
2025e	0.44 undefined
2024e	0.44 undefined
2023	0.42 undefined
2022	0.56 undefined
2021	0.43 undefined
2020	0.39 undefined
2019	0.32 undefined
2018	0.38 undefined
2017	0.35 undefined
2016	0.32 undefined
2015	0.28 undefined
2014	0.27 undefined
2013	0.21 undefined
2012	0.1 undefined
2011	0.1 undefined
2010	0.07 undefined
2009	0.07 undefined
2008	0.07 undefined
2007	0.05 undefined
2006	0.17 undefined
2005	0.08 undefined
2004	0.1 undefined

	Dividend	Dividend (Estimate)
2004	0.1 CNY	0 CNY
2005	0.08 CNY	0 CNY
2006	0.17 CNY	0 CNY
2007	0.05 CNY	0 CNY
2008	0.07 CNY	0 CNY
2009	0.07 CNY	0 CNY
2010	0.07 CNY	0 CNY
2011	0.1 CNY	0 CNY
2012	0.1 CNY	0 CNY
2013	0.21 CNY	0 CNY
2014	0.27 CNY	0 CNY
2015	0.28 CNY	0 CNY
2016	0.32 CNY	0 CNY
2017	0.35 CNY	0 CNY
2018	0.38 CNY	0 CNY
2019	0.32 CNY	0 CNY
2020	0.39 CNY	0 CNY
2021	0.43 CNY	0 CNY
2022	0.56 CNY	0 CNY
2023	0.42 CNY	0 CNY
2024e	0 CNY	0.44 CNY
2025e	0 CNY	0.44 CNY
2026e	0 CNY	0.44 CNY

Date	Shanghai Fosun Pharmaceutical Group Co Payout ratio
2026e	31.31 %
2025e	33.27 %
2024e	30.77 %
2023	29.89 %
2022	39.14 %
2021	23.27 %
2020	27.27 %
2019	24.62 %
2018	35.51 %
2017	27.56 %
2016	26.67 %
2015	26.42 %
2014	29.35 %
2013	29.58 %
2012	14.29 %
2011	16.39 %
2010	14.49 %
2009	4.94 %
2008	18.02 %
2007	15.08 %
2006	124.54 %
2005	76.92 %
2004	78.9 %

	Payout ratio
2004	78.9 %
2005	76.92 %
2006	124.54 %
2007	15.08 %
2008	18.02 %
2009	4.94 %
2010	14.49 %
2011	16.39 %
2012	14.29 %
2013	29.58 %
2014	29.35 %
2015	26.42 %
2016	26.67 %
2017	27.56 %
2018	35.51 %
2019	24.62 %
2020	27.27 %
2021	23.27 %
2022	39.14 %
2023	29.89 %
2024e	30.77 %
2025e	33.27 %
2026e	31.31 %

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2024	0.3	0.29 (-2.68 %)	2024 Q3
6/30/2024	0.28	0.23 (-18.67 %)	2024 Q2
3/31/2024	0.35	0.23 (-34 %)	2024 Q1
12/31/2023	0.41	0.04 (-90.22 %)	2023 Q4
9/30/2023	0.39	0.19 (-52.79 %)	2023 Q3
6/30/2023	0.33	0.3 (-8.62 %)	2023 Q2
3/31/2023	0.38	0.37 (-3.6 %)	2023 Q1
12/31/2022	0.38	0.48 (26.72 %)	2022 Q4
9/30/2022	0.41	0.34 (-16.89 %)	2022 Q3
6/30/2022	0.43	0.42 (-2.17 %)	2022 Q2
3/31/2022	0.37	0.18 (-51.83 %)	2022 Q1
12/31/2021	0.34	0.46 (33.95 %)	2021 Q4
9/30/2021	0.47	0.42 (-11.52 %)	2021 Q3
6/30/2021	0.96	0.33 (-65.61 %)	2021 Q2
3/31/2021	0.34	0.33 (-3.9 %)	2021 Q1
12/31/2020	0.44	0.46 (3.51 %)	2020 Q4
9/30/2020	0.31	0.3 (-4.18 %)	2020 Q3
6/30/2020	0.36	0.44 (22.7 %)	2020 Q2
3/31/2020	0.22	0.23 (6.73 %)	2020 Q1
12/31/2019	0.63	0.49 (-22.58 %)	2019 Q4
9/30/2019	0.29	0.22 (-23.58 %)	2019 Q3
6/30/2019	0.35	0.31 (-11.28 %)	2019 Q2
3/31/2019	0.33	0.28 (-14.71 %)	2019 Q1
12/31/2018	0.27	0.24 (-11.99 %)	2018 Q4
9/30/2018	0.35	0.2 (-43.42 %)	2018 Q3
6/30/2018	0.4	0.35 (-13.37 %)	2018 Q2
3/31/2018	0.33	0.28 (-15.99 %)	2018 Q1
12/31/2017	0.32	0.28 (-13.06 %)	2017 Q4
9/30/2017	0.31	0.29 (-7.53 %)	2017 Q3
6/30/2017	0.41	0.39 (-4.53 %)	2017 Q2
3/31/2017	0.31	0.31 (0.62 %)	2017 Q1
12/31/2016	0.29	0.26 (-11.23 %)	2016 Q4
9/30/2016	0.31	0.29 (-5.35 %)	2016 Q3
6/30/2016	0.35	0.37 (5.87 %)	2016 Q2
3/31/2016	0.28	0.27 (-4.53 %)	2016 Q1
12/31/2015	0.28	0.24 (-13.61 %)	2015 Q4
9/30/2015	0.3	0.25 (-17.49 %)	2015 Q3
6/30/2015	0.28	0.33 (16.69 %)	2015 Q2
3/31/2015	0.24	0.23 (-5.12 %)	2015 Q1
12/31/2014	0.28	0.23 (-19.1 %)	2014 Q4
9/30/2014	0.29	0.24 (-16.03 %)	2014 Q3
6/30/2014	0.34	0.25 (-25.04 %)	2014 Q2
12/31/2011	0.09	0.05 (-44.88 %)	2011 Q4

%	Name	Stocks	Change	Date
45.55898 %	Shanghai Fosun High Technology (Group) Co., Ltd.	961,424,455	75,108,500	9/12/2024
1.83559 %	China Securities Finance Corporation Ltd.	38,736,079	38,736,079	6/30/2024
1.44455 %	Dacheng Fund Management Co., Ltd.	30,484,035	0	6/30/2024
1.11524 %	China Merchants Fund Management Co. Ltd.	23,534,818	-681,100	6/30/2024
0.89042 %	E Fund Management Co. Ltd.	18,790,425	870,800	6/30/2024
0.70250 %	Huatai-PineBridge Fund Management Co., Ltd.	14,824,825	1,253,000	6/30/2024
0.49634 %	Yinhua Fund Management Co., Ltd.	10,474,235	-158,500	6/30/2024
0.44755 %	China Universal Asset Management Co., Ltd.	9,444,537	288,000	6/30/2024
0.39699 %	Tianhong Asset Management Co., Ltd.	8,377,592	938,400	6/30/2024
0.38759 %	GF Fund Management Co., Ltd.	8,179,177	-949,000	6/30/2024
0.36752 %	Harvest Fund Management Co., Ltd.	7,755,732	5,577,800	9/30/2024
0.36286 %	China Asset Management Co., Ltd.	7,657,452	-4,477,756	6/30/2024
0.21662 %	The Vanguard Group, Inc.	4,571,302	487,300	9/30/2024
0.13266 %	HuaAn Fund Management Co., Ltd.	2,799,504	-59,500	6/30/2024
0.12878 %	BlackRock Advisors (UK) Limited	2,717,560	72,500	9/30/2024
0.10085 %	BlackRock Institutional Trust Company, N.A.	2,128,189	27,500	9/30/2024
0.07728 %	Hwabao WP Fund Management Co., Ltd.	1,630,800	-84,800	6/30/2024
0.07160 %	Guotai Asset Management Co., Ltd.	1,510,960	24,200	6/30/2024
0.06540 %	Wu (Yifang)	1,380,100	0	12/31/2023
0.06287 %	Galaxy Asset Management Co., Ltd.	1,326,684	313,400	6/30/2024
0.05848 %	Rongtong Fund Management Co., Ltd.	1,234,200	1,234,200	6/30/2024
0.04526 %	Fullgoal Fund Management Co., Ltd.	955,182	-3,850,100	6/30/2024
0.04497 %	Handelsbanken Kapitalf¿rvaltning AB	948,900	40,000	9/30/2024
0.04488 %	Fortune & Royal Asset Management Company Limited	947,000	132,000	6/30/2024
0.04148 %	Penghua Fund Management Co., Ltd.	875,300	-1,206,391	6/30/2024
0.03989 %	ICBC Credit Suisse Asset Management Co. Ltd.	841,834	90,400	6/30/2024
0.03659 %	China Asset Management (Hong Kong) Limited	772,240	-77,200	7/31/2024
0.03612 %	AEGON-INDUSTRIAL Fund Management Co., Ltd.	762,200	224,200	6/30/2024
0.03607 %	Essence Fund Management Co., Ltd.	761,102	-198,000	6/30/2024
0.03390 %	Amundi Asset Management, SAS	715,460	13,400	9/30/2024
0.03307 %	Harvest Global Investments Limited	697,814	-4,500	9/30/2024
0.03171 %	China Southern Asset Management Co. Ltd.	669,151	78,300	6/30/2024
0.03029 %	DWS Investments UK Limited	639,146	-22,673	9/30/2024
0.02229 %	CPIC Fund Management Co., Ltd.	470,454	248,900	6/30/2024
0.02216 %	Wang (Ke Xin)	467,700	0	12/31/2023
0.02172 %	Yao (Fang)	458,300	0	12/31/2023
0.02015 %	State Street Global Advisors (US)	425,254	-3,739	9/30/2024
0.01981 %	Guan (Xiao Hui)	418,100	0	12/31/2023
0.01945 %	Mellon Investments Corporation	410,477	0	9/30/2024
0.01896 %	BlackRock (Singapore) Limited	400,179	-2,448	9/30/2024
0.01734 %	Zhong Ou Asset Management Co., Ltd.	365,900	241,600	6/30/2024
0.01651 %	CITIC Prudential Fund Management Co., Ltd.	348,335	-148,700	6/30/2024
0.01548 %	Taikang Asset Management Co., Ltd.	326,705	-64,600	6/30/2024
0.01517 %	Aviva Investors Global Services Limited	320,046	166	9/30/2024
0.01375 %	CCB Principal Asset Management Co., Ltd.	290,146	12,000	6/30/2024
0.01305 %	Western Leadbank Fund Management Co., Ltd.	275,329	-5,500	6/30/2024
0.01260 %	Tibet Eastmoney Fund Management Co., Ltd.	265,900	24,700	6/30/2024
0.01243 %	California State Teachers Retirement System	262,400	84,800	6/30/2023
0.01242 %	JPMorgan Asset Management (China) Company Limited.	262,100	-27,200	6/30/2024
0.01152 %	State Street Global Advisors (UK) Ltd.	243,176	-108,500	9/30/2024
0.01078 %	Goldman Sachs Asset Management, L.P.	227,489	0	9/30/2024
0.01076 %	Wen (Deyong)	227,100	0	12/31/2023
0.01053 %	Cardano Asset Management NV	222,285	2,501	8/31/2024
0.01030 %	China Life AMP Asset Management Co., Ltd	217,300	9,700	6/30/2024
0.00980 %	Geode Capital Management, L.L.C.	206,900	-300	8/31/2024
0.00920 %	SWS MU Fund Management Co., Ltd.	194,052	-21,400	6/30/2024
0.00911 %	UBS Asset Management (UK) Ltd.	192,300	0	9/30/2024
0.00882 %	Huashang Fund Management Co., Ltd.	186,100	186,100	6/30/2024
0.00876 %	BlackRock Investment Management (UK) Ltd.	184,800	0	8/31/2024
0.00872 %	Nuveen LLC	183,988	0	8/31/2024
0.00861 %	Krane Funds Advisors, LLC	181,629	-3,000	9/30/2024
0.00827 %	Northern Trust Global Investments Limited	174,600	300	8/31/2024
0.00782 %	First Seafront Fund Management Co., Ltd.	164,951	-50,300	6/30/2024
0.00764 %	Charles Schwab Investment Management, Inc.	161,200	0	9/30/2024
0.00704 %	PGGM Vermogensbeheer B.V.	148,597	31,105	7/31/2024
0.00662 %	LBP AM	139,804	-37,273	8/31/2024
0.00648 %	DWS Investment GmbH	136,775	-2,400	9/30/2024
0.00646 %	UBS Fund Management (Switzerland) AG	136,312	-8,600	9/30/2024
0.00628 %	HSBC Global Asset Management (UK) Limited	132,517	8,100	9/30/2024
0.00576 %	JP Morgan Asset Management	121,500	0	8/31/2024
0.00557 %	Fubon Asset Management Company Ltd.	117,545	-1,100	8/31/2024
0.00541 %	Z¿rcher Kantonalbank (Asset Management)	114,200	0	7/31/2024
0.00541 %	Hony Horizon Fund Management Co., Ltd.	114,100	-6,900	12/31/2023
0.00541 %	Chen (Qi Yu)	114,075	0	12/31/2023
0.00538 %	Li (Jing)	113,500	0	12/31/2023
0.00538 %	Feng (Rongli)	113,500	0	12/31/2023
0.00538 %	Wang (Donghua)	113,500	0	12/31/2023
0.00525 %	Amundi Japan Ltd.	110,850	-4,500	9/30/2024
0.00489 %	Mercer Global Investments Management Ltd	103,200	0	3/31/2024
0.00472 %	Pictet Asset Management Ltd.	99,600	0	6/30/2024
0.00427 %	Changsheng Fund Management Co., Ltd.	90,164	7,300	6/30/2024
0.00425 %	Nykredit Bank AS	89,601	48,901	9/30/2024
0.00418 %	Caitong Fund Management Co., Ltd.	88,200	1,100	6/30/2024
0.00415 %	BOCI-Prudential Asset Management Ltd.	87,500	0	8/31/2024
0.00403 %	UBS Asset Management (Switzerland)	85,000	0	8/31/2024
0.00390 %	ABC-CA Fund Management Co., Ltd.	82,242	-2,200	6/30/2024
0.00388 %	Dong (Xiao Xian)	81,800	0	12/31/2023
0.00381 %	Mei (Jing Ping)	80,300	0	12/31/2023
0.00360 %	Nuode Asset Management Company Limited	76,000	-77,200	6/30/2024
0.00358 %	Bosera Asset Management Co., Ltd.	75,500	-219,700	6/30/2024
0.00346 %	Legal & General Investment Management Ltd.	73,100	0	9/30/2024
0.00333 %	Xu (Aihua)	70,200	0	12/31/2023
0.00322 %	Wanjia Asset Management Co., Ltd.	68,049	-3,600	6/30/2024
0.00320 %	CICC Fund Management Co Ltd.	67,600	13,000	6/30/2024
0.00317 %	Liu (Yi)	66,800	0	12/31/2023
0.00317 %	Li (Dongjiu)	66,800	46,800	12/31/2023
0.00317 %	Bao (Qingui)	66,800	0	12/31/2023
0.00293 %	Mirae Asset Global Investments (Hong Kong) Limited	61,854	7,400	6/30/2024
0.00282 %	Franklin Advisers, Inc.	59,600	10,000	9/30/2024
0.00269 %	Zhu (Yue)	56,800	0	12/31/2023

What values and corporate philosophy does Shanghai Fosun Pharmaceutical Group Co represent?

Shanghai Fosun Pharmaceutical Group Co Ltd represents a set of core values and a strong corporate philosophy. With a focus on innovation, integrity, and social responsibility, the company strives to deliver high-quality pharmaceutical products and healthcare services. Shanghai Fosun Pharmaceutical Group Co Ltd believes in fostering sustainable development and prioritizes the well-being of patients and the community. The company's dedication to excellence, patient-centric approach, and continuous research and development efforts make it a prominent player in the pharmaceutical industry. Shanghai Fosun Pharmaceutical Group Co Ltd exemplifies a commitment to quality, ethical practices, and making a positive impact on society.

In which countries and regions is Shanghai Fosun Pharmaceutical Group Co primarily present?

The Shanghai Fosun Pharmaceutical Group Co Ltd primarily operates and has a significant presence in multiple countries and regions. The company is mainly active in China, where its headquarters is located. It also has a strong presence in various other regions and countries, including the United States, Europe, India, and Africa. Shanghai Fosun Pharmaceutical Group Co Ltd focuses on expanding its global footprint through strategic partnerships, collaborations, and acquisitions. With its diversified portfolio and global operations, the company continues to deliver innovative healthcare solutions and contribute to the well-being of people worldwide.

What significant milestones has the company Shanghai Fosun Pharmaceutical Group Co achieved?

Shanghai Fosun Pharmaceutical Group Co Ltd has achieved several significant milestones in its history. The company has demonstrated consistent growth and expansion, becoming one of the leading pharmaceutical companies in China. It has successfully developed and marketed various innovative drugs, contributing to improved healthcare outcomes for patients. Shanghai Fosun Pharmaceutical Group Co Ltd has also made strategic acquisitions and formed partnerships to strengthen its market presence both domestically and internationally. Additionally, the company has received recognition for its commitment to research and development, as well as its contributions to healthcare philanthropy. These achievements make Shanghai Fosun Pharmaceutical Group Co Ltd a formidable player in the pharmaceutical industry.

What is the history and background of the company Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co Ltd, commonly known as Fosun Pharma, is a leading Chinese pharmaceutical company. Established in 1994, the company has a rich history and a strong background in the healthcare industry. Fosun Pharma focuses on research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medicines, and medical devices. Over the years, Fosun Pharma has expanded its presence globally and has become one of the largest comprehensive healthcare groups in China. With a commitment to innovation and high-quality products, Shanghai Fosun Pharmaceutical Group Co Ltd continues to make significant contributions to the advancement of healthcare worldwide.

Who are the main competitors of Shanghai Fosun Pharmaceutical Group Co in the market?

The main competitors of Shanghai Fosun Pharmaceutical Group Co Ltd in the market include multinational pharmaceutical companies such as Johnson & Johnson, Pfizer, Novartis, and GlaxoSmithKline. These competitors are well-established players in the global pharmaceutical industry and offer a wide range of products and services similar to Shanghai Fosun Pharmaceutical Group. As Shanghai Fosun Pharmaceutical Group aims to expand globally and capture a larger market share, it faces strong competition from these industry giants. However, Shanghai Fosun Pharmaceutical Group has its unique strengths, product portfolio, and innovative strategies to differentiate itself and gain a competitive advantage in the market.

In which industries is Shanghai Fosun Pharmaceutical Group Co primarily active?

Shanghai Fosun Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Shanghai Fosun Pharmaceutical Group Co?

The business model of Shanghai Fosun Pharmaceutical Group Co Ltd focuses on various aspects of the pharmaceutical industry. As a leading healthcare company, it engages in research and development, manufacturing, sales, and distribution of pharmaceutical products. Shanghai Fosun Pharmaceutical Group Co Ltd is committed to promoting innovation and improving the accessibility of healthcare products and services. It operates through segments such as pharmaceutical manufacturing, research and development, distribution and retail, and medical services. By leveraging its strong industry expertise and strategic partnerships, Shanghai Fosun Pharmaceutical Group Co Ltd aims to contribute to the advancement of healthcare and provide high-quality medical solutions to customers worldwide.

What is the P/E ratio of Shanghai Fosun Pharmaceutical Group Co 2024?

The Shanghai Fosun Pharmaceutical Group Co P/E ratio is 30.78.

What is the P/S ratio of Shanghai Fosun Pharmaceutical Group Co 2024?

The Shanghai Fosun Pharmaceutical Group Co P/S ratio is 1.66.

What is the Quality Investing of Shanghai Fosun Pharmaceutical Group Co?

The Quality Investing for Shanghai Fosun Pharmaceutical Group Co is 3/10.

What is the revenue of Shanghai Fosun Pharmaceutical Group Co 2024?

The expected Shanghai Fosun Pharmaceutical Group Co revenue is 42.86 B CNY.

How high is the profit of Shanghai Fosun Pharmaceutical Group Co 2024?

The expected Shanghai Fosun Pharmaceutical Group Co profit is 2.31 B CNY.

What is the business model of Shanghai Fosun Pharmaceutical Group Co

The Shanghai Fosun Pharmaceutical Group Co Ltd is a leading company in the development, manufacturing, and marketing of pharmaceutical products and medical services. The business model is based on a diversified portfolio of business activities focused on various segments of the healthcare industry. The company's first division is the manufacturing of pharmaceutical products. Shanghai Fosun Pharma produces a wide range of medical products, including drugs, diagnostics, and medical devices. The company specializes in innovative drug manufacturing to offer high-quality medical solutions to its customers, with a strong emphasis on product quality. Another important division is research and development. Shanghai Fosun Pharma invests significantly in researching and developing new drugs and therapies. The company collaborates closely with international partners to develop innovative technologies and products that meet market needs. In addition to these activities, the company also operates hospitals, healthcare centers, and care facilities. Shanghai Fosun Pharma is a leading provider of high-quality healthcare services in China. The company strives to offer its customers a comprehensive range of services focused on the needs of patients. Furthermore, the group also has a subsidiary, Fosun Industrial Co Ltd, specializing in the manufacturing and marketing of chemicals and plastic products. This perfectly complements the company's portfolio and enables it to serve more customers. The company also offers various health products, including dietary supplements, medical aids, and wellness products. These products are sold in the company's own pharmacies as well as retail pharmacies nationwide. Shanghai Fosun Pharma also operates in overseas markets, with branches in various countries around the world. The company aims to bring product quality and innovation to the global market in order to make them accessible to an even larger part of society. In summary, the business model of Shanghai Fosun Pharmaceutical Group Co Ltd is based on innovation and differentiation through research and development, manufacturing, and distribution of drugs, medical services, and products. The company has a strong presence in the healthcare market and delivers world-leading products and services.

What is the Shanghai Fosun Pharmaceutical Group Co dividend?

Shanghai Fosun Pharmaceutical Group Co pays a dividend of 0.56 CNY distributed over payouts per year.

How often does Shanghai Fosun Pharmaceutical Group Co pay dividends?

The dividend cannot currently be calculated for Shanghai Fosun Pharmaceutical Group Co or the company does not pay out a dividend.

What is the Shanghai Fosun Pharmaceutical Group Co ISIN?

The ISIN of Shanghai Fosun Pharmaceutical Group Co is CNE000000X38.

What is the Shanghai Fosun Pharmaceutical Group Co ticker?

The ticker of Shanghai Fosun Pharmaceutical Group Co is 600196.SS.

How much dividend does Shanghai Fosun Pharmaceutical Group Co pay?

Over the past 12 months, Shanghai Fosun Pharmaceutical Group Co paid a dividend of 0.42 CNY . This corresponds to a dividend yield of about 1.57 %. For the coming 12 months, Shanghai Fosun Pharmaceutical Group Co is expected to pay a dividend of 0.44 CNY.

What is the dividend yield of Shanghai Fosun Pharmaceutical Group Co?

The current dividend yield of Shanghai Fosun Pharmaceutical Group Co is 1.57 %.

When does Shanghai Fosun Pharmaceutical Group Co pay dividends?

Shanghai Fosun Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of August, July, September, September.

How secure is the dividend of Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co paid dividends every year for the past 23 years.

What is the dividend of Shanghai Fosun Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.44 CNY are expected. This corresponds to a dividend yield of 1.66 %.

In which sector is Shanghai Fosun Pharmaceutical Group Co located?

Shanghai Fosun Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanghai Fosun Pharmaceutical Group Co from 8/6/2024 amounting to 0.27 CNY, you needed to have the stock in your portfolio before the ex-date on 8/6/2024.

When did Shanghai Fosun Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of Shanghai Fosun Pharmaceutical Group Co in the year 2023?

In the year 2023, Shanghai Fosun Pharmaceutical Group Co distributed 0.56 CNY as dividends.

In which currency does Shanghai Fosun Pharmaceutical Group Co pay out the dividend?

The dividends of Shanghai Fosun Pharmaceutical Group Co are distributed in CNY.

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.03	0.33	0.18	0.34	0.37	0.63	1.24	0.69	0.75	0.99	1.08	1.01	1.31	3.56	3.13	5.2	3.11	3.73	4.13	6.05	7.47	9.16	9.99	11.93	13.58	16.94	15.33
0.05	0.05	0.1	0.12	0.17	0.24	0.3	0.39	0.46	0.48	0.45	0.45	0.56	0.84	0.93	0.91	1.29	1.5	1.74	1.97	3.25	3.62	4.37	4.57	6.03	7.59	7.79
0.08	0.05	0.03	0.09	0.13	0.14	0.22	0.11	0.12	0.27	0.22	0.35	0.23	0.42	0.66	0.76	0.76	0.69	0.62	0.8	1.28	1.42	1.58	1.81	2.01	1.55	1.91
0.05	0.05	0.1	0.08	0.12	0.36	0.31	0.47	0.53	0.61	0.5	0.53	0.6	0.93	1.12	1.27	1.61	1.61	1.65	1.67	2.75	3.29	3.94	5.16	5.47	6.88	7.54
0.01	0.03	0.06	0.03	0.26	0.05	0.03	0.1	0.1	0.07	0.27	0.08	0.61	0.16	0.22	0.24	0.21	1.14	0.19	0.29	0.31	0.5	0.53	1.61	3.33	2.32	1.23
0.22	0.51	0.47	0.66	1.05	1.41	2.1	1.76	1.96	2.42	2.52	2.42	3.31	5.91	6.05	8.38	6.99	8.67	8.33	10.77	15.06	18	20.4	25.09	30.42	35.28	33.79
0.04	0.07	0.2	0.24	0.35	0.57	0.78	1.05	1.24	1.26	1.14	1.15	1.26	1.69	2.63	3.57	5.06	5.84	5.92	6.39	8.41	9.37	11.43	13.26	14.44	17.4	23.67
0.02	0.05	0.21	0.58	0.77	1.03	1.18	2.12	2.24	2.59	3.47	3.68	6.66	8.18	10.24	10.05	11.61	14.41	17.23	18.85	21.12	24.06	23.02	23.77	23.92	25.55	25.01
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	189	77.4	212.8	282.07
0	0	0.02	0.03	0.04	0.1	0.1	0.18	0.2	0.21	0.21	0.2	0.21	0.53	1.71	1.78	2.64	2.91	3.25	3.65	8.28	9.19	10.97	11.5	13.43	15.93	17.38
0	0	0	0	0	0	0	0	0	0.05	0.05	0.05	0.05	0.34	1.59	1.66	2.98	3.26	3.3	3.47	8.46	8.85	9.01	8.68	9.4	10.34	10.85
0.01	0.01	0.02	0.02	0.01	0.04	0.05	0.03	0.03	0.06	0.05	0.04	0.04	0.18	0.08	0.06	0.21	0.26	0.18	0.64	0.64	1.07	1.29	1.21	1.59	2.47	2.48
0.07	0.13	0.44	0.87	1.17	1.74	2.1	3.39	3.71	4.18	4.92	5.12	8.22	10.92	16.24	17.13	22.49	26.67	29.88	33	46.92	52.55	55.72	58.6	62.87	71.88	79.68
0.29	0.64	0.92	1.53	2.22	3.15	4.21	5.15	5.67	6.59	7.44	7.54	11.53	16.83	22.29	25.51	29.47	35.34	38.2	43.77	61.97	70.55	76.12	83.69	93.29	107.16	113.47

0.06	0.15	0.23	0.29	0.29	0.38	0.38	0.83	0.83	0.95	1.24	1.24	1.24	1.9	1.9	2.24	2.24	2.31	2.31	2.42	2.5	2.56	2.56	2.56	2.56	2.67	2.67
0	0.3	0.22	0.67	0.73	0.69	0.72	0.76	0.82	1.48	1.49	1.06	1.16	1.83	2.21	4.29	6.28	6.15	6.06	7.86	9.08	10.55	12.14	15.13	14.03	16.99	16.85
0.05	0.06	0.16	0.15	0.25	0.4	0.59	0.71	0.74	0.61	1.14	1.71	4.08	4.69	5.67	7.04	5.63	7.12	8.93	11.12	13.37	15.15	17.65	20.23	23.87	26.17	27.5
0	0	0	0	0	0	0	0	-0	0	0	0	0	-0	-0.01	-0.01	1.18	1.12	0.92	0.83	0.4	-0.28	-0.47	-0.93	-1.38	-1.18	-1.06
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	113.9	-18.79	-236.87
0.1	0.51	0.6	1.11	1.27	1.47	1.69	2.29	2.39	3.05	3.87	4.01	6.48	8.42	9.77	13.56	15.33	16.7	18.23	22.22	25.34	27.98	31.89	37	39.19	44.64	45.73
0.05	0.04	0.07	0.07	0.09	0.32	0.32	0.41	0.47	0.41	0.27	0.36	0.46	0.73	0.76	0.78	0.99	0.83	0.97	1.03	1.65	2.18	2.15	2.94	4.52	5.43	5.51
0	0.01	0.01	0.01	0.01	0.04	0.04	0.07	0.06	0.09	0.05	0.08	0.07	0.11	0.21	0.31	0.48	0.59	0.61	0.75	0.88	1.03	0.98	1.13	1.51	1.89	2.33
0.08	0.03	0.07	0.11	0.13	0.2	0.32	0.28	0.3	0.26	0.25	0.28	0.35	0.93	1.66	1.3	2.24	3.09	1.94	2.06	3.47	4.03	5.14	5.22	6.41	7.3	5.33
0.02	0	0.06	0.13	0.63	0.78	0.48	0.75	0.87	1.45	1.46	0.98	1.11	1.88	1.78	1.15	1.53	3.91	5.55	4.45	9.85	5.76	6.6	8.66	11.75	13.27	15.84
0	0	0	0	0	0	0	0	0.01	0.14	0.18	0.06	0.5	0.06	0.59	0.36	0.04	1.11	1.86	1.82	0.76	4.93	2.56	6.92	5.13	5.41	4.75
0.15	0.07	0.22	0.32	0.86	1.34	1.17	1.51	1.71	2.34	2.22	1.76	2.5	3.7	4.99	3.89	5.28	9.54	10.94	10.11	16.6	17.92	17.43	24.87	29.31	33.3	33.76
0	0.03	0	0.03	0.03	0.05	1.02	0.75	0.98	0.55	0.75	1.18	1.29	2.76	3.92	4.28	4.2	3.88	3.59	5.58	9.82	12.69	12.99	9.34	9.9	13.04	15.89
0	0	0	0	0	0	0	0	0	0	0.07	0.08	0.7	0.87	1.6	1.36	1.78	1.93	1.85	1.79	2.98	2.91	2.99	2.85	3.13	3.36	3.45
0	0.01	0.01	0	0	0.01	0.01	0.11	0.1	0.1	0.09	0.08	0.09	0.1	0.42	0.67	0.55	0.89	1.16	1.04	2.83	3.44	3.5	0.64	2.57	3.36	3.76
0	0.04	0.01	0.03	0.03	0.05	1.03	0.86	1.09	0.64	0.9	1.34	2.08	3.72	5.93	6.31	6.53	6.7	6.59	8.41	15.63	19.04	19.48	12.83	15.61	19.76	23.1
0.15	0.12	0.23	0.35	0.88	1.39	2.2	2.37	2.79	2.98	3.12	3.09	4.58	7.42	10.92	10.2	11.81	16.23	17.53	18.52	32.23	36.96	36.92	37.7	44.92	53.05	56.85
0.26	0.63	0.84	1.46	2.16	2.86	3.89	4.66	5.19	6.03	6.99	7.1	11.05	15.84	20.69	23.76	27.14	32.93	35.76	40.74	57.57	64.94	68.81	74.7	84.11	97.69	102.58

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	2.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	-188
66	-37	-52	-107	-150	-199	-308	-347	-341	-497	-470	-570	-535	-1,220	-2,103	-3,171	-3,721	-4,956	-5,976	-7,424	-11,359	-13,569	-12,871	-15,073	-18,041
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-2,996	-572
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-14	-24	-14	-40	-65	-129	-239	-205	-185	-184	-209	-336	-363	-616	-755	-963	-1,171	-1,395	-1,560	-1,959	-2,410	-2,275	-2,196	-1,836	-1,609
0.07	0.04	0.14	0.07	0.1	0.15	0.21	0.19	0.18	0.13	0.23	0.26	0.2	0.32	0.67	1.01	1.2	1.62	2.11	2.58	2.95	3.22	2.58	3.95	4.22
-52	-78	-126	-141	-139	-264	-205	-222	-266	-209	-210	-348	-339	-796	-1,160	-1,040	-1,119	-1,235	-1,922	-2,170	-3,174	-3,962	-4,437	-4,972	-5,888
-99	-238	-443	-487	-150	162	-779	-437	-336	-53	56	-397	-264	-1,766	-978	-1,803	-2,478	-1,869	-2,447	-10,504	-5,244	-172	-4,706	-3,856	-4,064
-0.05	-0.16	-0.32	-0.35	-0.01	0.43	-0.57	-0.22	-0.07	0.16	0.27	-0.05	0.07	-0.97	0.18	-0.76	-1.36	-0.63	-0.53	-8.33	-2.07	3.79	-0.27	1.12	1.82
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.02	0.01	0.08	0.5	0.09	-0.29	0.16	0.35	0.8	0.38	-0.09	0.68	1.72	1.52	-0.46	-0.03	3.09	2	0.57	8.93	2.39	-2.44	2.25	1.81	3.75
372	77	435	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.34	0.04	0.47	0.45	0.02	0.59	0.01	0.15	0.37	0.14	-0.35	0.4	1.82	0.91	2.07	-0.93	1.86	0.55	1.45	9.91	3.14	-1.94	1.47	-0.83	4.43
-0	-0.03	-0.04	0.04	0.02	0.98	0.01	0.03	-0	0.02	0.02	0.02	0.48	-0.06	3.23	0.15	-0.1	-0.34	2.07	2.41	4.3	2.37	1.05	-0.73	3.06
-7	-10	-4	-84	-91	-105	-149	-228	-428	-258	-277	-302	-378	-543	-707	-1,058	-1,126	-1,109	-1,193	-1,433	-3,551	-1,864	-1,834	-1,913	-2,374
0.32	-0.06	0.37	0.25	0.29	1.38	0.19	0.64	0.93	1.03	0.85	1.43	2.86	1.61	5.27	3.39	6.69	8.31	10.84	13.78	17.55	20.18	16.69	19.98	28.58
14.4	-39.8	11.8	-73.3	-37	-114	0.1	-34.3	-81.7	-78.2	22.4	-86.2	-135.8	-480.2	-495.1	-28.5	80.8	385.5	188	409.6	-224.8	-739.7	-1,857.3	-1,023.84	-1,671.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - Direct Emissions	210,819
Scope 2 - Indirect emissions from purchased energy	677,874
Scope 3 - Indirect emissions within the value chain	72,171
Total CO₂ emissions	888,693
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	49.529
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.19	0.34	0.49	0.57	0.73	1.03	2.16	2.43	2.99	4.08	3.69	3.77	3.87	4.56	6.49	7.34	10	12.03	12.61	14.63	18.53	24.92	28.59	30.31	39.01	43.95	41.4	42.86	46.62	48.72
-	78.95	43.24	16.43	28.40	41.76	108.82	12.53	23.26	36.57	-9.53	2.17	2.62	17.64	42.39	13.18	36.17	20.31	4.85	16.02	26.69	34.44	14.72	6.02	28.70	12.68	-5.81	3.53	8.77	4.51
36.84	37.06	42.71	43.56	37.23	34.40	26.91	31.22	29.98	21.34	26.59	27.67	32.02	33.90	37.63	43.62	44.22	43.87	49.78	53.81	58.84	58.34	59.57	55.47	47.97	47.09	47.54	45.92	42.22	40.40
0.07	0.13	0.21	0.25	0.27	0.36	0.58	0.76	0.9	0.87	0.98	1.04	1.24	1.54	2.44	3.2	4.42	5.28	6.28	7.87	10.91	14.54	17.03	16.81	18.71	20.7	19.68	0	0	0
0.04	0.06	0.09	0.1	0.14	0.15	0.26	0.22	0.16	0.26	0.63	0.69	2.5	0.86	1.17	1.56	1.58	2.11	2.46	2.81	3.12	2.71	3.32	3.66	4.74	3.73	2.39	2.31	2.76	3.23
-	55.00	50.00	10.75	38.83	2.80	76.19	-16.99	-26.05	62.26	142.64	10.38	261.51	-65.41	34.95	34.13	1.21	33.48	16.42	14.07	11.33	-13.32	22.67	10.26	29.27	-21.22	-36.03	-3.02	19.19	17.01
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.55	1.42	1.42	1.49	1.49	1.49	1.49	1.61	1.62	1.86	1.86	1.86	1.86	1.89	1.9	2.24	2.24	2.3	2.32	2.33	2.46	2.52	2.56	2.56	2.56	2.61	2.67	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Shanghai Fosun Pharmaceutical Group Co Ticker	Shanghai Fosun Pharmaceutical Group Co FIGI
600196:CH	BBG000C4SR52
600196:CG	BBG000C4SRF1
600196:C1	BBG00709HHX2

Access the world's leading financial data and tools

Price

Price

Ticker600196.SS

ISINCNE000000X38

Shanghai Fosun Pharmaceutical Group Co stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Shanghai Fosun Pharmaceutical Group Co Stock Price History

Shanghai Fosun Pharmaceutical Group Co Revenue, EBIT, Net Income CNE000000X38 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Shanghai Fosun Pharmaceutical Group Co Revenue, EBIT and net profit per share

Shanghai Fosun Pharmaceutical Group Co Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Shanghai Fosun Pharmaceutical Group Co stock margins CNE000000X38 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Shanghai Fosun Pharmaceutical Group Co Margin History

Shanghai Fosun Pharmaceutical Group Co Stock Sales Revenue, EBIT, Earnings per Share CNE000000X38 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Shanghai Fosun Pharmaceutical Group Co Revenue, EBIT and net profit per share

Shanghai Fosun Pharmaceutical Group Co business model

Shanghai Fosun Pharmaceutical Group Co SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Shanghai Fosun Pharmaceutical Group Co Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Shanghai Fosun Pharmaceutical Group Co historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Shanghai Fosun Pharmaceutical Group Co shares outstanding CNE000000X38 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Shanghai Fosun Pharmaceutical Group Co stock splits

Shanghai Fosun Pharmaceutical Group Co dividend history and estimates CNE000000X38 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Shanghai Fosun Pharmaceutical Group Co Dividend History

Ticker
600196.SS

ISIN
CNE000000X38